Opportunities of immunotherapy in dogs with B-cell lymphoma

A study examined dog that were treated with chemo-immunotherapy and compared with dogs treated with chemotherapy only.  Three hundred dogs were included: 148 (49.3%) received chemotherapy and 152 (50.7%) chemo-immunotherapy.

Results showed that dogs receiving chemo-immunotherapy survived significantly longer. Among dogs with diffuse large B-cell lymphoma, the  survival rates were 51% for one year, 19% for year 2, and 10% for year 3 for dogs treated with chemo-immunotherapy.

Read more by clicking on the link below:

Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers.

 

 

Previous
Previous

Health Canada warns Canadians of potential cancer risk associated with gentian violet

Next
Next

The prevalence of pulmonary hypertension in Cavalier King Charles spaniels